Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CUR

Neuralstem (CUR)

Neuralstem Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CUR
DateTimeSourceHeadlineSymbolCompany
03/19/20211:15PMGlobeNewswire Inc.NeuroRx Announces Dosing of First Patient with ZYESAMIâ„¢ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...NASDAQ:CURNeuralstem Inc
09/02/20208:00AMPR Newswire (US)Letter from Seneca Biopharma's Executive ChairmanNASDAQ:CURNeuralstem Inc
05/27/202011:00AMPR Newswire (US)Seneca Biopharma Announces the Closing of its $5 Million Registered Direct OfferingNASDAQ:CURNeuralstem Inc
11/04/20194:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
10/31/201911:00AMPR Newswire (US)Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCANASDAQ:CURNeuralstem Inc
10/30/20197:00AMPR Newswire (US)Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...NASDAQ:CURNeuralstem Inc
10/30/20196:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
10/28/201911:24PMPR Newswire (US)Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership SummitNASDAQ:CURNeuralstem Inc
10/28/20199:00AMPR Newswire (US)Neuralstem Becomes Seneca BiopharmaNASDAQ:CURNeuralstem Inc
10/11/20197:34PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
10/11/20197:32PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CURNeuralstem Inc
10/11/20197:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
10/11/20197:28PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
10/11/20197:26PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
10/11/20197:24PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
10/03/20199:31AMPR Newswire (US)Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)NASDAQ:CURNeuralstem Inc
09/24/20194:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
09/24/20197:30AMPR Newswire (US)Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...NASDAQ:CURNeuralstem Inc
09/17/20195:00PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
08/14/20192:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
08/14/20197:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CURNeuralstem Inc
08/14/20197:30AMPR Newswire (US)Neuralstem Reports Second Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
08/09/20199:05AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CURNeuralstem Inc
08/07/20199:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
08/07/20197:30AMPR Newswire (US)Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued ListingNASDAQ:CURNeuralstem Inc
07/31/20197:30AMPR Newswire (US)Neuralstem Closes $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
07/29/20194:47PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CURNeuralstem Inc
07/26/20196:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CURNeuralstem Inc
07/25/201910:40PMPR Newswire (US)Neuralstem Announces Pricing of $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
07/25/20196:05AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:CURNeuralstem Inc
 Showing the most relevant articles for your search:NASDAQ:CUR